Biphasic effect of alcohol intake on the development of fatty liver disease

Journal of Gastroenterology

Volumn 50, Issue 11, 2015, Pages 1114-1123

  Takahashi, Hirokazu ^a   Ono, Masafumi ^b   Hyogo, Hideyuki ^c   Tsuji, Chika ^a,d   Kitajima, Yoichiro ^a,d   Ono, Naofumi ^d   Eguchi, Takahisa ^d   Fujimoto, Kazuma ^a   Chayama, Kazuaki ^c   Saibara, Toshiji ^b   Anzai, Keizo ^a   Eguchi, Yuichiro ^a  

^a SAGA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^d Eguchi Hospital   (Japan)

Author keywords

Alcoholic; NAFLD; NASH; Obesity; Prevalence; Ultrasonography

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL; ALCOHOL;

ABDOMINAL RADIOGRAPHY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; AGE; ALCOHOLISM; ANTHROPOMETRY; COMPLICATION; DRINKING BEHAVIOR; FATTY LIVER, ALCOHOLIC; JAPAN; MIDDLE AGED; PREVALENCE; PROCEDURES; SEX DIFFERENCE;

ADULT; AGE FACTORS; ALCOHOL DRINKING; ALCOHOLISM; ANTHROPOMETRY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ETHANOL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84946491681     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1058-z     Document Type: Article

References (45)

1. Bedogni G, Miglioli L, Masutti F, et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology. 2007;46:1387–91.
2. Pendino GM, Mariano A, Surace P, et al. Prevalence and etiology of altered liver tests: a population—based survey in a Mediterranean town. Hepatology. 2005;41:1151–9.
3. Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol. 2005;3:1260–8.
4. Bizzaro N, Tremolada F, Casarin C, et al. Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity. Ital J Gastroenterol. 1992;24:237–41.
5. Kondili LA, Taliani G, Cerga G, et al. Correlation of alcohol consumption with liver histological features in non–cirrhotic patients. Eur J Gastroenterol Hepatol. 2005;17:155–9.
6. Maher JJ. Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis. 2002;13:31–9.
7. Zhou YJ, Li YY, Nie YQ, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13:6419–24.
8. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7.
9. Michitaka K, Nishiguchi S, Aoyagi Y, et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45:86–94.
10. Suzuki A, Angulo P, St Sauver J, et al. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol. 2007;102:1912–9.
11. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology. 2008;47:1947–54.
12. Gunji T, Matsuhashi N, Sato H, et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104:2189–95.
13. Hiramine Y, Imamura Y, Uto H, et al. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol. 2011;46:519–28.
14. Miyake T, Kumagi T, Hirooka M, et al. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community—based retrospective longitudinal cohort study. J Gastroenterol. 2013;48:413–22.
15. Sogabe M, Okahisa T, Hibino S, Yamanoi A. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males. J Gastroenterol. 2012;47:293–9.
16. Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. J Gastroenterol. 2015;50:95–108.
17. Eguchi Y, Hyogo H, Ono M, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47:586–95.
18. Tanaka K, Hyogo H, Ono M, et al. Upper limit of normal serum alanine aminotransferase levels in Japanese subjects. Hepatol Res. 2014;44:1196–207.
19. The World Medical Association, Inc. Declaration of Helsinki; Ethical principle for medical research involving human subject. Seoul: WMA General Assembly; 2008.
20. Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.
21. Guy J, Peters MG. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (NY). 2013;9:633–9.
22. Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23:1025–9.
23. Lieber CS. Gender differences in alcohol metabolism and susceptibility. In: Wilsnack RW, Wilsnack SC, editors. Gender and alcohol: individual and social perspectives. Piscataway: Rutgers Center of Alcohol Studies; 1997. p. 77–89.
24. Nolen-Hoeksema S. Gender differences in risk factors and consequences for alcohol use and problems. Clin Psychol Rev. 2004;24:981–1010.
25. Frezza M, di PC, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first–pass metabolism. N Engl J Med. 1990;322:95–9.
26. Ikejima K, Enomoto N, Iimuro Y, et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol. 1998;274(4 pt 1):G669–76.
27. Dixon JB, Bhathal PS, O’ Brien PE. Non-alcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.
28. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high–calorie diet. Nature. 2006;444:337–42.
29. Tomie Furuya D, Binsack R, Onishi ME, et al. Low ethanol consumption induces enhancement of insulin sensitivity in liver of normal rats. Life Sci. 2005;77:1813–24.
30. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005;82:675–84.
31. Davies MJ, Baer DJ, Judd JT, et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.
32. Feng L, Gao L, Guan Q, et al. Long–term moderate ethanol consumption restore insulin sensitivity in high–fat–fed rats by increasing SLCA4 (GLUT4) in the adipose tissue by AMP–activated kinase activation. J Endocrinol. 2008;199:95–104.
33. Sierksma A, Patel H, Ouchi N, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor–alpha, and insulin sensitivity. Diabetes Care. 2004;27:184–9.
34. Yang CM, Carlson GP. Effects of ethanol on glutathione conjugation in rat liver and lung. Biochem Pharmacol. 1991;41:923–9.
35. Guarino MP, Afonso RA, Raimundo N, et al. Hepatic glutathione and nitric oxide are critical for hepatic insulin sensitizing substance action. Am J Physiol Gastrointest Liver Physiol. 2003;284:G588–94.
36. Feng L, Han B, Wang R, et al. The frequency of daily ethanol consumption influences the effect of ethanol on insulin sensitivity in rats fed a high–fat diet. Br J Nutr. 2012;107:850–7.
37. Lopez-Garcia E, Guallar-Castillon P, Leon-Muñoz L, et al. Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis. 2013;231:152–7.
38. Xu YY, Bhavani K, Wands JR, et al. Ethanol inhibits insulin receptor substrate–1 tyrosine phosphorylation and insulin–stimulated neuronal thread protein gene expression. Biochem J. 1995;310:125–32.
39. Bhavani K, de la Monte SM, Brown NV, et al. Effect of ethanol on p36 protein kinase substrate and insulin receptor substrate 1 expression and tyrosyl phosphorylation in human hepatocellular carcinoma cells. Alcohol Clin Exp Res. 1995;19:441–6.
40. Onishi Y, Honda M, Ogihara T, et al. Ethanol feeding induces insulin resistance with enhanced PI 3–kinase activation. Biochem Biophys Res Commun. 2003;303:788–94.
41. Lindtner C, Scherer T, Zielinski E, et al. Binge drinking induces whole–body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med. 2013;5:170ra14.
42. Yki-Järvinen H, Nikkilä EA. Ethanol decreases glucose utilization in healthy man. J Clin Endocrinol Metab. 1985;61:941–5.
43. Yki-Järvinen H, Koivisto VA, Ylikahri R, et al. Acute effects of ethanol and acetate on glucose kinetics in normal subjects. Am J Physiol. 1988;254:E175–80.
44. O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol. 2010;105:14–32.
45. Mendenhall CL. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis. 1968;13:783–91.